Periodic Reporting for period 3 - MammaPrint (Improved breast cancer care by innovative diagnostic test MammaPrint)

Summary
Agendia NV, a Dutch SME founded in 2003 as spin-off from the Netherlands Cancer Institute, is a commercial-stage molecular diagnostic company.Agendia focusses on the discovery, development and commercialization of innovative products to improve the quality of life for cancer...
More information & hyperlinks